A fatal pasteurella empyema

Kagihara, Jamie M; Brahmbhatt, Nishal; Paladino, Jonathan

doi:10.1016/s0140-6736(14)60922-3

Cited by 4 publications

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pasteurella multocida ( P. multocida ) is a gram-negative coccobacillus and zoonotic microbe found in the oral flora of cats (70%), dogs, and other mammals [ 1 , 2 ]. Most patients with P. multocida infection have an underlying cardiopulmonary disease and/or are immunocompromised (57%) [ 3 ].…”

Section: Introductionmentioning

confidence: 99%

Empyema Caused by Pasteurella multocida in a Patient With Chronic Obstructive Respiratory Disease Taking Inhaled Corticosteroids: A Case Report

Odaka¹,

Asahi²,

Shimada³

et al. 2023

Cureus

View full text Add to dashboard Cite

Pasteurella multocida (P. multocida) infection develops in patients with chronic obstructive pulmonary disease (COPD). Inhaled corticosteroids (ICS) are used for the treatment of COPD. Herein, we report a case of empyema caused by P. multocida in a patient using ICS for COPD. A 79-year-old man with COPD presented with general fatigue. He was treated with triple therapy including ICS. Contrast-enhanced computed tomography revealed encapsulated pleural effusion in the left chest. We initiated antibiotics, sulbactam sodium/ampicillin sodium (3 g × 4), and thoracic drainage. His pleural effusion culture turned out positive and P. multocida was detected. The patient was diagnosed with empyema caused by P. multocida. The triple therapy combination, including ICS, was changed to a double therapy combination without ICS. The subsequent progress was relatively good, and on the 49th day of hospitalization, the patient was discharged. The onset of P. multocida infection may be associated with ICS use, which may best be avoided in a patient with COPD who is at risk of P. multocida infection.

show abstract

Section: Introductionmentioning

confidence: 99%

Empyema Caused by Pasteurella multocida in a Patient With Chronic Obstructive Respiratory Disease Taking Inhaled Corticosteroids: A Case Report

Odaka¹,

Asahi²,

Shimada³

et al. 2023

Cureus

View full text Add to dashboard Cite

show abstract

Pasteurella multocida pleural effusion: A case report and review of literature

Jogani

Subedi

Chopra

et al. 2016

Respiratory Medicine Case Reports

View full text Add to dashboard Cite

We describe a man who developed pleural effusion with Pasteurella multocida, and review the reported literature concerning this entity. We identified 21 such cases, including our own. Most patients with P. multocida pleural effusions are immunocompromised and/or have significant co-morbidities. These effusions are typically complicated parapneumonic effusions that are grossly purulent (87%) with a low pleural fluid pH (mean 6.8), high protein (mean 4.8 g/dl) and high LDH (mean 1911 U/L) and low glucose (28.6 mg/dl). Pleural fluid drainage with tube thoracostomy was required in the majority (62%) of cases.

show abstract

Antimicrobial Therapy for Pasteurella multocida Empyema in Immunocompetent Adults

Parthvi¹,

Sunil²

2018

American Journal of Therapeutics

View full text Add to dashboard Cite

A fatal pasteurella empyema

Cited by 4 publications

References 4 publications

Empyema Caused by Pasteurella multocida in a Patient With Chronic Obstructive Respiratory Disease Taking Inhaled Corticosteroids: A Case Report

Empyema Caused by Pasteurella multocida in a Patient With Chronic Obstructive Respiratory Disease Taking Inhaled Corticosteroids: A Case Report

Pasteurella multocida pleural effusion: A case report and review of literature

Antimicrobial Therapy for Pasteurella multocida Empyema in Immunocompetent Adults

Contact Info

Product

Resources

About